Zelira Therapeutics Ltd has released a press release.
Quarterly Report and Appendix 4C
Filed with ASX ·
6ix hasn’t read this filing yet.
Zelira Therapeutics Ltd. on 6ix
Earlier from Zelira Therapeutics
- Zelda to Test Formulations Against Pancreatic Cancer
- Sleep Disorder Clinical Trials Update
- Collaboration Agreement with Telethon Kids Institute
- Significant Anti-Cancer Effect Observed in Studies
- Zelda expands its Intellectual Property portfolio
Later from Zelira Therapeutics
- Appendix 4D & FY17 Interim Financial Report
- New Licence Agreement
- Clinical Trials to Commence in Chile
- Zelda Enters Strategic Partnership with CannPal
- Zelda Successfully Completes Capital Raising
Follow Zelira Therapeutics into a list and get an email when it puts out news.
Follow Zelira Therapeutics